Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

e real underlying value of the company. One announcement can change the share price dramatically. We have created a late stage cancer company with very large potential both to help patients and create profit, particularly since Multikine is not toxic. What is the value of such a product? Once proven to work, probably billions of dollars. Therefore I believe that our value should be much higher today than the current share price, particularly since a cancer drug is not really related to the economic conditions. If we are successful in just some of the projects listed above, the additional value should very quickly be recognized and the current times will be quickly forgotten.

In closing, we believe that the immune system holds the key to treating cancer. We believe that Multikine will be a multi-billion dollar drug because it works with the body to destroy those tumor metastases thought to be responsible for recurrence of the tumor. In our Phase II studies, Multikine when given for only 3 weeks prior to the normal treatment was able to eliminate all tumor in 12% of the patients, reduce the number of tumor cells by an average of 50% in the treatment group and increase long-term overall survival by 33%. This is why you are a shareholder in CEL-SCI! Tell a friend about our great results.

We thank you for your continued support.

Sincerely,

Geert Kersten

Chief Executive Officer

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be s
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014  World Hemp Oil, ... low THC, announces they are now offering legal, organic ... Charlotte,s Web type strains grown in medical marijuana states. ... neurological disorders, such as Parkinson,s, MS, and spinal cord ... laws to pass, because imported CBD Oil Is legal ...
(Date:11/21/2014)... Nov. 21, 2014  Abaxis, Inc. (NasdaqGS: ... and consumables for the medical, research, and veterinary markets ... and research markets in the United States ... purchase agreement to acquire 100% of QCR & Trio ... based distribution organization. The transaction closed on November 17, ...
(Date:11/21/2014)... MONTREAL , 21. November 2014 ... hat heute bekannt gegeben, dass ... – EMA) die Kennzeichnung als Orphan-Medizinprodukt ... Produktkandidat des Unternehmens zur Behandlung von ... eine seltene, stark beeinträchtigende genetische Krankheit, ...
Breaking Medicine Technology:New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 2New CBD Oil From Industrial Hemp is Comparable to Charlotte's Web, Legal In All 50 States 3Abaxis Acquires UK-based Distribution Organization 2Abaxis Acquires UK-based Distribution Organization 3Abaxis Acquires UK-based Distribution Organization 4Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3
... June 21, 2011 Robbins & Myers, Inc. (NYSE: ... of Directors has approved its regular quarterly cash dividend ... on August 5, 2011 to shareholders of record as ... Inc. is a leading supplier of engineered equipment and ...
... 2011 Reportlinker.com announces that a new market ... The Outlook for Medical Devices in ... Detailed analysis of four ... global medical device market and which present immense ...
Cached Medicine Technology:Reportlinker Adds The Outlook for Medical Devices in North East Asia 2Reportlinker Adds The Outlook for Medical Devices in North East Asia 3Reportlinker Adds The Outlook for Medical Devices in North East Asia 4
(Date:11/24/2014)... Abington, PA (PRWEB) November 24, 2014 ... Nataliya Ternopolska, MD has joined The Neurology ... Abington Health’s Multiple Sclerosis Center. , A graduate ... residency in Neurology at Albert Einstein Medical Center in ... the Judith Jaffe Multiple Sclerosis Center at Weill Cornell ...
(Date:11/24/2014)... New York (PRWEB) November 24, 2014 ... contacted by the Family and Children's Association ... such as soap, shampoo, mouthwash and other such items.The ... citizens who are home bound, living in nursing homes, ... intended to greatly enhance the well being of seniors ...
(Date:11/24/2014)... 24, 2014 ReAdmission Solutions, LLC ... management services to health plans, hospitals, and accountable ... Management software suite. ReAdmission Solutions will use ... program to reduce patients' avoidable readmissions to hospitals. ... Care Management, Utilization Management, and Appeals & Grievances. ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled ... They are now offered at deeply discounted prices, up ... now to Dec. 15. The main purpose of the promotion ... high quality items are ideal options for ladies who are ... money. All its new mint cocktail dresses are very beautiful; ...
(Date:11/23/2014)... 23, 2014 Nearly 260 testosterone ... strokes, deep vein thrombosis and other serious cardiovascular ... multidistrict litigation (MDL) underway in the Northern District ... Court documents updated on November 17th by the ... the filing of 259 lawsuits against the makers ...
Breaking Medicine News(10 mins):Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 2Health News:Testosterone Lawsuits Approach 260 in Illinois Federal Court Litigation, Bernstein Liebhard LLP Reports 3
... life is a myth, argues a senior doctor in a letter ... Kelly Taylor, a terminally ill woman who went to court earlier ... morphine, even though it will hasten her death. ... the principle of double effect is a puzzling choice, writes Claud ...
... health and reduce days off work and school, according to ... state of housing has a real impact on health; cold ... likely to be damp - leading to respiratory problems. Despite ... little is known about the specific health effects of the ...
... women are at a higher risk of perinatal mortality (death ... black or white women// , concludes a study published online ... defines post-term pregnancy as beyond 41 completed weeks from the ... associated with increased perinatal mortality, and induction of labour at ...
... Administration (FDA) and the Centers for Disease Control and Prevention ... that has not been// pasteurized, known as raw milk. ... – including Salmonella, E. coli O157:H7, Listeria, Campylobacter and Brucella ... ,Consuming raw milk may be harmful to health. ...
... and family difficulties account for about half of all ... family therapy work chiefly with couples.// The therapist helps ... and unstated assumptions that perpetuate conflict, explains the March ... ,Couples therapists make little use of psychiatric ...
... at the University of Illinois have found that a molecular ... bone cancer in humans is also critical to the pathology// ... lead to advances in the palliative care of companion animals ... U. of I. pathobiology professor Anne Barger, examined the homeostatic ...
Cached Medicine News:Health News:Insulating Houses Improves Health and Wellbeing 2Health News:FDA and CDC Remind Consumers of the Dangers of Drinking Raw Milk 2Health News:Insights into Osteosarcoma in Cats and Dogs may Improve Palliative Care 2
... single-use is designed to saturate dry eyes, ... very dry eyes. For maximum hydration and ... dosing--splitting the entire contents of one container, ... after opening at least 4 times a ...
POLYSORB™ sutures are composed of LACTOMER™ glycolide/lactide copolymer which is a synthetic polyester composed of glycolide and lactide (derived from glycolic and lactic acids)....
Surgitie&trade Single Use Ligating Loops with Delivery System...
Surgitie&trade Single Use Ligating Loops without Delivery System with POLYSORB™....
Medicine Products: